Skip to content

NUTRAPHAR BE

Active
Private limited companyfounded 2024active for 2 yearsAvenue Baudouin de Changy 4, 1380 Lasne, BelgiumKBO/BCE: BE 1012.754.333
Summary

NUTRAPHAR BE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€2,910) and a net result of -€7,910. Its solvency ranks better than 15% of 74 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21209
1 site
Size
€1,779total assets 2025
Equity
-€2,910
Loss
-€7,910
Turnover not published (micro format)
Financial health
54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.0%
Structure
2025 accounts filed 12 days late
Why 54raises riskCapped at 59: negative equityNegative equity -€2,910Founded in 2024lowers riskSize: total assets €1,779Liquidity: current ratio 0.38, cash €1,091Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 24% of its sector peers (NACE 21, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Weak
Solvency 0
equity -163.5% of total assets
Liquidity 50
short-term debt 263.5% · cash 61.3%
Profitability 0
return on assets -444.5%
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (154 companies, NACE 21, micro)
Last 24 months 09-2025: 1.2% 10-2025: 1.2%● unchanged vs 09-2025 11-2025: 1.3%▲ +0.1 percentage points vs 10-2025 12-2025: 1.4%▲ +0.1 percentage points vs 11-2025 01-2026: 1.5%▲ +0.1 percentage points vs 12-2025 02-2026: 1.6%▲ +0.1 percentage points vs 01-2026 03-2026: 1.6%● unchanged vs 02-2026 04-2026: 1.8%▲ +0.2 percentage points vs 03-2026 05-2026: 1.8%● unchanged vs 04-2026 06-2026: 1.7%▼ -0.1 percentage points vs 05-2026 07-2026: 1.9%▲ +0.2 percentage points vs 06-2026 08-2026: 2.0%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 1.0%▼ -1.0 percentage point vs 08-2026lowest value 10-2026: 1.0%● unchanged vs 09-2026lowest value
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro): better than 10% on solvency, 49% on liquidity and 13% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Negative equity -€2,910
NBB · annual accounts
lowers risk · Size: total assets €1,779
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.38, cash €1,091
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
raises risk · 2025 accounts filed 12 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
12 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointments: Dominique HAVERBEKE (director) and…

Financials · financial year 2025, micro format

2025 annual accounts filed late (12 days) Filed on 12 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00396338.

Equity
-€2,910
Total assets
€1,779
Net result
-€7,910
Working capital
-€2,910

Turnover and EBIT margin not published: the micro format does not require them.

Key figures and ratios
2025 value
Debt
€4,689
Debt ≤ 1 year
€4,689
Ratios withheld: a balance sheet total of €1,779 is too small for a meaningful ratio.

Peer companies

Historical observation

Of the 7,639 companies that looked in July 2024 the way this one looks now, 8.8% went bankrupt within 24 months and 84.8% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.8% went bankrupt
5.6% stopped otherwise
84.8% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 1.0% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 23 lines
Balance sheet Code2025
Assets
Total assets20/58€1,779
Current assets29/58€1,779
Amounts receivable within one year40/41€688
Other amounts receivable41€688
Cash at bank and in hand54/58€1,091
Equity and liabilities
Total equity and liabilities10/49€1,779
Equity10/15-€2,910
Contributions10/11€5,000
Profit (loss) carried forward14-€7,910
Amounts payable17/49€4,689
Amounts payable within one year42/48€4,689
Trade debts44€295
Suppliers440/4€295
Other amounts payable47/48€4,394
Income statement Code2025
Other operating charges640/8€387
Gross operating margin9900-€7,450
Operating profit (loss)9901-€7,838
Financial charges65/66B€72
Recurring financial charges65€72
Profit (loss) for the period before taxes9903-€7,910
Profit (loss) for the period9904-€7,910
Profit (loss) for the period to be appropriated9905-€7,910
Appropriation of the result
Profit (loss) to be appropriated9906-€7,910

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€387
Gross operating margin9900-€7,450
Operating profit (loss)9901-€7,838
Financial charges65/66B€72
Recurring financial charges65€72
Profit (loss) for the period before taxes9903-€7,910
Profit (loss) for the period9904-€7,910
Profit (loss) for the period to be appropriated9905-€7,910
Line2025
Assets
Total assets20/58€1,779
Current assets29/58€1,779
Amounts receivable within one year40/41€688
Other amounts receivable41€688
Cash at bank and in hand54/58€1,091
Equity and liabilities
Total equity and liabilities10/49€1,779
Equity10/15-€2,910
Contributions10/11€5,000
Profit (loss) carried forward14-€7,910
Amounts payable17/49€4,689
Amounts payable within one year42/48€4,689
Trade debts44€295
Suppliers440/4€295
Other amounts payable47/48€4,394
Line2025
Profit (loss) for the period9904-€7,910
Operating cash flow (approximation)-€7,910

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
31-12-2025 micro format 12-08-2026 2026-00396338

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 97 active companies whose main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209), figures are known for 76. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
2 directors, no change since 2024
Dominique HAVERBEKE
Director (not named in the articles) · since 27-08-2024
Current
Patrick BONTINCK
Director (not named in the articles) · since 27-08-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

2 people since 2024, 2 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
Dominique HAVERBEKE
  • Director (not named in the articles), from 27-08-2024 to date
Patrick BONTINCK
  • Director (not named in the articles), from 27-08-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 27-08-2024 ↗
  • HAVERBEKE Philippe Jean-Paul sole founder · 100% at incorporation

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 27-08-2024 Incorporation · €5,000 · 100 shares

Group and network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

NUTRAPHAR BE was incorporated on 23 August 2024 as a private limited company by one natural person, with a starting capital of €5,000.12 The board currently has 2 members; 2 of them have served since 2024.2 The company has filed annual accounts once, for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 27-08-2024
  3. 3National Bank, annual accounts 2025

Acts, filings and financial milestones

2026
12-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 12 days late
2024
27-08
Gazette deed Incorporation
Appointments: Dominique HAVERBEKE (director) and Patrick BONTINCK (director) · Founder · Founding capital7 facts ▸
  • Founder, HAVERBEKE Philippe Jean-Paul
  • Incorporation, 23-08-2024
  • Founding capital, €5,000
  • Capital
  • Registered office clause, “1380 Lasne,Avenue Baudouin de Changy 4” (deed in French)
  • Director appointment, Dominique HAVERBEKE (director (not named in the articles))
  • Director appointment, Patrick BONTINCK (director (not named in the articles))
Gazette deedNBB filing
1 of 1 deed read

Register details

Identification
Legal formPrivate limited company
Founded23-08-2024
Financial year end31-12
Activities, NACEBEL 2025
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
10890Manufacture of food products
46389Wholesale of other food products
46460Wholesale of pharmaceutical and medical goods
Contact
E-mail phaverbeke@nutraphar.chLasne
E-invoicing
Reachable via Peppol
Peppol ID 0208:1012754333
Registered 06-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Lasneunit no. 2.363.310.572
1 permission
Groothandelaar LM>3 maand · since 27-11-2025

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Lasne · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
5,456 m²
Building footprint
203 m²
Building volume
891 m³
Parcel 25051G0057/00B002, Wallonia · tallest building 6.3 m. Linked by address, not a title deed.
1 establishment unit
NUTRAPHAR BE
Avenue Baudouin de Changy 4, 1380 LasneManufacture of basic pharmaceutical products and pharmaceutical preparations
since 2024unit no. 2.363.310.572
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25051G0057/00B002 Wallonia 5,456 m² 1 · 203 m² 6.3 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Importation,exportation,commercialisation et promotion de compléments alimentaires et de tous produits assimilés ; toutes prestations de…” (deed in French)
5 activities (deed in French)
  1. Importation,exportation,commercialisation et promotion de compléments alimentaires et de tous produits assimilés ; toutes prestations de services et toutes opérations convergentes à ces buts.
  2. Elle peut accomplir toutes opérations commerciales,industrielles,financières,mobilières ou immobilières se rapportant directement ou indirectement à son objet tant en Belgique qu’à l’étranger.
  3. Elle peut s’intéresser pour toutes voies dans toutes sociétés,associations,ou entreprises ayant un objet similaire ou connexe au sien ou susceptible de favoriser le développement de ses activités ou constituer pour elle une source de débouchés.
  4. Elle pourra ainsi participer à la création d’entreprises commerciales,financières,industrielles ou immobilières et leur prêter tout concours,que ce soit par des prêts,des garanties ou de tout autre manière.
  5. La société peut être administrateur ou liquidateur.

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
NUTRAPHAR BE
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Région wallonne, sièges administratifs,agences,ateliers,dépôts et succursales,tant en Belgique qu'à l'étranger” (deed in French)

deed of 27-08-2024

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation de durée, organe d'administration” (deed in French)
“Indépendamment des frais de représentation,voyages et déplacements, assemblée générale” (deed in French)

deed of 27-08-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Nominatives, actions” (deed in French)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Moitié cédant moitié acquéreurs proportionnellement si plusieurs, mêmes formalités si non actionnaires de plein droit” (deed in French)

deed of 27-08-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Wednesday of June at 18:00

deed of 27-08-2024

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one.
No statutory auditor
Dissolution ruleWhen and by whom the company can be dissolved.
“En tout temps par décision de l'assemblée générale dans formes des modifications aux statuts” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Dissolution pour quelque cause et à quelque moment que ce soit, faculté assemblée de désigner un ou plusieurs liquidateurs et déterminer…” (deed in French)

deed of 27-08-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Compte de capitaux propres statutairement indisponible, susceptibles de distribution aux actionnaires” (deed in French)
Other provision: “Apport en numéraire avec émission de nouvelles actions - droit de préférence, courrier électronique,ou courrier ordinaire même jour si pas…” (deed in French)
Other provision: “Nominatifs avec numéro d’ordre, nature des autres titres” (deed in French)
Other provision: “Titres indivisibles,un seul propriétaire par titre pour exercice des droits, indivisibilité des titres” (deed in French)
Other provision: “Organe détermine s'ils agissent seul ou conjointement, gestion journalière et représentation pour cette gestion” (deed in French)
Other provision: “Contrôle de la société, lorsque la loi l'exige et dans les limites qu'elle prévoit” (deed in French)
Other provision: “Assemblée générale par procédure écrite, membres organe,commissaire et titulaires d'obligations convertibles,droits de souscription ou…” (deed in French)
Other provision: “Assemblées générales électroniques, vote à distance et questions écrites, règlement peut soumettre utilisation à conditions” (deed in French)
Other provision: “Séances et procès-verbaux, liste de présences,rapports,procurations,votes par correspondance” (deed in French)
Other provision: “Chaque action une voix,sous réserve actions sans droit de vote, délibérations” (deed in French)
Other provision: “Pouvoirs de l'assemblée générale, exerce pouvoirs conférés par le Code des sociétés et des associations” (deed in French)
Other provision: “Répartition et réserves, moitié bénéfice net aux réserves,moitié distribuée si conditions légales remplies” (deed in French)
Liquidation distribution: “Répartition de l'actif net, apurement dettes,charges,frais ou consignation” (deed in French)
Other provision: “Au siège pour communications,sommations,assignations,significations, élection de domicile” (deed in French)
Other provision: “Compétence judiciaire, entre société,actionnaires,gérants,commissaires,liquidateurs relatifs aux affaires et exécution statuts” (deed in French)
Other provision: “Droit commun, dispositions CSA auxquelles il ne serait pas licitement dérogé réputées inscrites,clauses contraires impératives censées non…” (deed in French)
Other provision: “Dispositions finales et transitoires, décisions du comparant effectives à dater du dépôt au greffe d'une expédition de l'acte constitutif…” (deed in French)
3 more provisions in the deed, see the deed of 27-08-2024

deed of 27-08-2024